---
figid: PMC5822899__IJE2018-2637418.001
figtitle: The main intracellular pathways and the effects of drugs used in dyslipidemia
  and obesity in (A) differentiation of preadipocytes into mature adipocytes
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5822899
filename: IJE2018-2637418.001.jpg
figlink: /pmc/articles/PMC5822899/figure/fig1/
number: F1
caption: 'Schematic illustration of the main intracellular pathways and the effects
  of drugs used in dyslipidemia and obesity in (A) differentiation of preadipocytes
  into mature adipocytes. This process is on dependence of the PKA pathway, which
  activates transcriptional factors such as C/EBPB, C/EBPd, C/EBPa, and PPARG that
  ultimately lead to increase of adipogenesis gene expression. Statins and liraglutide
  inhibit adipogenesis while niacin and fibrates stimulate, by inducing upregulation
  of adipogenesis genes (∗leptin; adiponectin, FABP4, perilipin, and GLUT4, SCD1)
  expression and (B) immune and endocrine functions of WAT. Adipocyte exerts autocrine
  and paracrine actions, through secreting adipokines and also endocrine actions in
  distant organs. Most of the drugs exhibit an anti-inflammatory role through modulation
  of adipokine expression. Through modulation of leucocyte chemotaxis, they also affect
  NK cell activity and macrophage phagocytosis. See text for more details. →: stimulates;
  ⊣: inhibits; AC: adenylyl cyclase; cAMP: cyclic adenosine monophosphate; PKA: cAMP-dependent
  protein kinase A; C/EBP: CCATT enhancer-binding proteins; PPARs: peroxisome proliferator-activated
  receptors; SREBP1: sterol regulatory element-binding protein-1; RXTα: retinoid X
  receptor-α; SRE: sterol response elements; SRB1: scavenger receptor 1; NK cells:
  natural killer cells; CD40: cluster of differentiation 40; CD40L: CD40 ligand; 11B-HSD1:
  11B-Hydroxysteroid dehydrogenase type 1; TNFα: tumour necrosis factor α; IL: interleukin;
  CCL2 or MCP1: CC-chemokine ligand 2; PAI-1: plasminogen activator inhibitor type
  1; AdipoR: adiponectin receptor; IL1RA: IL1 receptor antagonist; IFN-γ: interferon-γ;
  TLR: Toll-like receptors; NFκB: nuclear factor kappa B; SRB1: scavenger receptor
  1; VCAM1: vascular cell adhesion molecule-1; E-selectin: endothelial-leukocyte adhesion
  molecule-1; ICAM1: intracellular adhesion molecule-1; OBRb: leptin receptor; ERK:
  extracellular signal-regulated kinase; MAPK: p38 mitogen-activated protein kinases;
  iNOS: inducible nitric oxide synthase; ROS: reactive oxygen species; TNFR: TNF receptor;
  IKKB: NFκB kinase-B; JNK: Jun N-terminal kinase; ER: endoplasmic reticulum; IR:
  insulin receptor (IR); IRS: insulin receptor substrate; UCP: uncoupling protein;
  CAP1: adenylyl cyclase-associated protein 1; ET1: endothelin-1.'
papertitle: 'Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose
  Tissue.'
reftext: Sofia Dias, et al. Int J Endocrinol. 2018;2018:2637418.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8415145
figid_alias: PMC5822899__F1
figtype: Figure
redirect_from: /figures/PMC5822899__F1
ndex: ff14483d-df23-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5822899__IJE2018-2637418.001.html
  '@type': Dataset
  description: 'Schematic illustration of the main intracellular pathways and the
    effects of drugs used in dyslipidemia and obesity in (A) differentiation of preadipocytes
    into mature adipocytes. This process is on dependence of the PKA pathway, which
    activates transcriptional factors such as C/EBPB, C/EBPd, C/EBPa, and PPARG that
    ultimately lead to increase of adipogenesis gene expression. Statins and liraglutide
    inhibit adipogenesis while niacin and fibrates stimulate, by inducing upregulation
    of adipogenesis genes (∗leptin; adiponectin, FABP4, perilipin, and GLUT4, SCD1)
    expression and (B) immune and endocrine functions of WAT. Adipocyte exerts autocrine
    and paracrine actions, through secreting adipokines and also endocrine actions
    in distant organs. Most of the drugs exhibit an anti-inflammatory role through
    modulation of adipokine expression. Through modulation of leucocyte chemotaxis,
    they also affect NK cell activity and macrophage phagocytosis. See text for more
    details. →: stimulates; ⊣: inhibits; AC: adenylyl cyclase; cAMP: cyclic adenosine
    monophosphate; PKA: cAMP-dependent protein kinase A; C/EBP: CCATT enhancer-binding
    proteins; PPARs: peroxisome proliferator-activated receptors; SREBP1: sterol regulatory
    element-binding protein-1; RXTα: retinoid X receptor-α; SRE: sterol response elements;
    SRB1: scavenger receptor 1; NK cells: natural killer cells; CD40: cluster of differentiation
    40; CD40L: CD40 ligand; 11B-HSD1: 11B-Hydroxysteroid dehydrogenase type 1; TNFα:
    tumour necrosis factor α; IL: interleukin; CCL2 or MCP1: CC-chemokine ligand 2;
    PAI-1: plasminogen activator inhibitor type 1; AdipoR: adiponectin receptor; IL1RA:
    IL1 receptor antagonist; IFN-γ: interferon-γ; TLR: Toll-like receptors; NFκB:
    nuclear factor kappa B; SRB1: scavenger receptor 1; VCAM1: vascular cell adhesion
    molecule-1; E-selectin: endothelial-leukocyte adhesion molecule-1; ICAM1: intracellular
    adhesion molecule-1; OBRb: leptin receptor; ERK: extracellular signal-regulated
    kinase; MAPK: p38 mitogen-activated protein kinases; iNOS: inducible nitric oxide
    synthase; ROS: reactive oxygen species; TNFR: TNF receptor; IKKB: NFκB kinase-B;
    JNK: Jun N-terminal kinase; ER: endoplasmic reticulum; IR: insulin receptor (IR);
    IRS: insulin receptor substrate; UCP: uncoupling protein; CAP1: adenylyl cyclase-associated
    protein 1; ET1: endothelin-1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - crq
  - E(spl)mgamma-HLH
  - ACC
  - tacc
  - acclinal-wing
  - Hsl
  - AcCoAS
  - Acsl
  - bmm
  - Tg
  - Cpt
  - CG7149
  - CPT2
  - Hdl
  - SNF4Agamma
  - AMPKalpha
  - srl
  - Pkg21D
  - for
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - GC
  - ATPsynbeta
  - Atpalpha
  - Mondo
  - Anp
  - mgl
  - Dgat2
  - Gat
  - mdy
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CD36
  - LPL
  - LCP1
  - ACACA
  - BMS1
  - ACACB
  - SLC2A4
  - LIPE
  - PLA2G15
  - ACSS2
  - ACCS
  - PNPLA2
  - TG
  - CHPT1
  - DHDDS
  - LPAL2
  - APOA1
  - HSD11B1
  - ALB
  - APOA2
  - APOE
  - CLU
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PPARGC1A
  - NR1H3
  - PDE3B
  - PRKG1
  - MTG1
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ATP8A2
  - MLXIPL
  - NPPA
  - NPPB
  - CLEC10A
  - MGLL
  - AKR1B10
  - DGAT1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Orlistat
  - Gemfibrozil
  - Glucose
  - Acetyl-CoA
  - Malonyl
  - Pitavastatin
  - Acyl
  - CGMP
  - ATP
  - Catecholamines
  - Niacin
---
